Core Viewpoint - Mould Technology (000700) clarified that its subsidiary, Mingci Hospital, is a tertiary specialized hospital for cardiovascular diseases and that the company currently has no business, technology, or investments related to brain-machine interfaces [1] Group 1 - The company operates Mingci Hospital, which specializes in cardiovascular care [1] - There are no current operations or investments in brain-machine interface technology [1]

Group 1 - The core viewpoint of the article is that Mould Technology (000700.SZ) clarified its business focus, stating that it does not engage in brain-machine related businesses, technologies, or investments [1] - The company operates a cardiovascular tertiary specialty hospital, Mingci Hospital, which is part of its healthcare segment [1] - The interaction on the platform indicates a clear communication from the company regarding its current business operations and future direction [1]